Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach | PLOS ONE
Anticoagulation therapy in Atrial Fibrillation patients at high bleeding risk - It's Over 9000!
Eliquis Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer | NEJM
ELIQUIS (apixaban) label
Target-Specific Oral Anticoagulants
Eliquis Dosage/Direction for Use | MIMS Malaysia
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect
Frontiers | Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
Missouri Society of Health-System Pharmacists - Pharmacist Continuing Education: From DOACs to ROACs: Strategies for Reversing Oral Anticoagulants
DVT Prophylaxis After Hip/Knee Surgery|ELIQUIS® (apixaban) Safety Info
Apixaban: An Oral Anticoagulant
Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study
Direct Oral Anticoagulants are High-Risk Medications with Potentially Complex Dosing | PSNet
Eliquis in the Management of NVAF and VTE - ppt download
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS IRELAND
Eliquis Full Prescribing Information, Dosage & Side Effects | MIMS Indonesia
Eliquis: Package Insert / Prescribing Information - Drugs.com
ELIQUIS® (apixaban) dosing for NVAF patients | ELIQUIS UK
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review | Article
Apixaban (Eliquis) for Stroke Prevention in Atrial Fibrillation | AAFP
NOAC Dose-Adjustment Recommendations in Renal Impairment and AF | Download Table
